Gerona Roy, Tomer Daniel, Nielsen Donovan, Sage Allyson C, French Deborah, Tolles Juliana, Chenoweth James Alan
Department of OB/Gyn and Reproductive Sciences, University of California, San Francisco, San Francisco, CA, United States.
Department of Emergency Medicine, University of California, Davis, Davis, CA, United States.
Front Toxicol. 2025 Jun 25;7:1572324. doi: 10.3389/ftox.2025.1572324. eCollection 2025.
Motor vehicle crashes (MVCs) are a major global health concern. While alcohol continues to be a significant contributor to MVCs, the role of illicit and prescription drugs has increased in the last 4 decades. Moreover, the proliferation of new psychoactive substances (NPS) in the United States since 2010 has reshaped recreational drug use. Despite this, its contribution to MVCs has not been systematically evaluated. In this study, we report the prevalence of NPS in roadway crash victims in California.
Serum samples from 1000 roadway crash victims were collected and analyzed using liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF/MS) against a comprehensive database of 1314 drugs, including 1008 NPS, and quantitative analysis was performed using isotope dilution. Alcohol was quantified in an autoanalyzer using an enzymatic method employing alcohol dehydrogenase.
Eight NPS (detection frequency = 26) were confirmed and quantified in 17 cases. Like current nationwide NPS surveillance studies, bromazolam, para-fluorofentanyl, and mitragynine were most frequently detected. NPS were detected in polypharmacy use, with traditional recreational drugs such as fentanyl, methamphetamine, and delta-9 THC most frequently co-detected. The serum geometric means detected for bromazolam (5.41 ng/mL; range: 0.22-26.59), para-fluorofentanyl (0.45 ng/mL; range: 0.28-2.02) and mitragynine (7.02; range: 0.55-90.55) were lower than those reported for overdose and death cases.
This study is the first to report quantitative levels of multiple NPS and multiple NPS classes in a large US roadway crash survey, with the high detection of CNS depressants and their co-occurrence with traditional recreational drugs highlighting the need for expanded NPS testing, roadside testing strategies, and guidelines for determining drug-induced impairment; the quantitative data may be valuable in establishing these guidelines.
机动车碰撞事故(MVC)是全球主要的健康问题。虽然酒精仍然是导致机动车碰撞事故的一个重要因素,但在过去40年里,非法药物和处方药的作用有所增加。此外,自2010年以来,新型精神活性物质(NPS)在美国的激增重塑了娱乐性药物的使用情况。尽管如此,其对机动车碰撞事故的影响尚未得到系统评估。在本研究中,我们报告了加利福尼亚州道路交通事故受害者中新型精神活性物质的流行情况。
收集了1000名道路交通事故受害者的血清样本,并使用液相色谱-四极杆飞行时间质谱(LC-QTOF/MS)针对一个包含1314种药物的综合数据库进行分析,其中包括1008种新型精神活性物质,并使用同位素稀释法进行定量分析。使用采用乙醇脱氢酶的酶法在自动分析仪中对酒精进行定量。
在17例病例中确认并定量了8种新型精神活性物质(检测频率=26)。与当前全国性的新型精神活性物质监测研究一样,溴唑仑、对氟芬太尼和帽柱木碱的检测频率最高。新型精神活性物质在多药合用中被检测到,最常与芬太尼、甲基苯丙胺和δ-9四氢大麻酚等传统娱乐性药物共同检测到。检测到的溴唑仑(5.41纳克/毫升;范围:0.22-26.59)、对氟芬太尼(0.45纳克/毫升;范围:0.28-2.02)和帽柱木碱(7.0(范围:0.55-90.55)的血清几何平均值低于过量用药和死亡病例报告的值。
本研究首次在美国大型道路交通事故调查中报告了多种新型精神活性物质和多种新型精神活性物质类别的定量水平,中枢神经系统抑制剂的高检出率及其与传统娱乐性药物的同时出现凸显了扩大新型精神活性物质检测、路边检测策略以及确定药物引起的损害的指南的必要性;这些定量数据可能对制定这些指南有价值。